Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AF Ablation Attracts Stronger Support In Updated Clinical Guidelines

This article was originally published in The Gray Sheet

Executive Summary

The growing use of catheter ablation to treat atrial fibrillation is supported by increasingly strong evidence, though the procedure should remain, for now, a second-line therapy to antiarrhythmic drugs, according to U.S. cardiology society guideline updates issued Dec. 20.

You may also be interested in...

AF Ablation: Surgery And Catheter Techniques Both Shine At AHA

Atrial fibrillation treatments involving standalone surgical ablation and catheter ablation were discussed in data presentations at the American Heart Association annual meeting last week.

News In Brief

Arctic Front moves in

HRS A-Fib Ablation Consensus Statement Offers Clinical Trial Advice

A new expert 1consensus statement on ablation of atrial fibrillation, created by a Heart Rhythm Society task force, includes 21 specific recommendations for the design and conduct of clinical trials of AF ablation devices

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts